tradingkey.logo
搜索

Pacific Biosciences of California Inc

PACB
添加自选
1.680USD
-0.060-3.45%
收盘 07/02, 13:00美东报价延迟15分钟
507.29M总市值
亏损市盈率 TTM

Pacific Biosciences of California Inc

1.680
-0.060-3.45%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-3.45%

5天

+1.82%

1月

+3.07%

6月

-8.70%

今年开始到现在

-10.16%

1年

+5.00%

关键数据
1.730今开
1.835最高
5.38M成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
1.78%换手率
1.740昨收
1.670最低
6.26M成交额
亏损市盈率静
94.84市净率
0.00%股息率 TTM
-15.65%ROA
2.73052周最高
1.01量比
-309.85M净利润
301.96M总股本
-0.4133每股收益TTM
2.36Beta
-273.55%ROE
0.96052周最低
9.48%振幅
32.30%毛利率
507.29M总市值
1.32回报/风险
5.13%风险率

操作建议

Pacific Biosciences of California Inc当前公司基本面数据相对谨慎,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名124/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价2.46。中期看,股价处于上升通道。近一个月,市场表现一般,但技术面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Pacific Biosciences of California Inc评分

相关信息

行业排名
124 / 204
全市场排名
297 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Pacific Biosciences of California Inc亮点

亮点风险
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
利润高增长
公司净利润处于行业前列,最新年度总收入160.00M美元
估值低估
公司最新PE估值-4.07,处于3年历史低位
机构减仓
最新机构持股192.85M股,环比减少9.18%
凯茜·伍德(木头姐)持仓
明星投资者凯茜·伍德(木头姐)持仓,最新持仓市值37.12M

分析师目标

根据 8 位分析师
买入
评级
2.458
目标均价
+41.28%
涨幅空间

Pacific Biosciences of California Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Pacific Biosciences of California Inc简介

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which detects the nucleotide sequence and epigenetic status of individual deoxyribonucleic acid molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
公司代码PACB
公司Pacific Biosciences of California Inc
CEOHenry (Christian O)
网址https://www.pacb.com/

常见问题

Pacific Biosciences of California Inc(PACB)的当前股价是多少?

Pacific Biosciences of California Inc(PACB)的当前股价是 1.68。

Pacific Biosciences of California Inc的股票代码是什么?

Pacific Biosciences of California Inc的股票代码是PACB。

Pacific Biosciences of California Inc股票的52周最高点是多少?

Pacific Biosciences of California Inc股票的52周最高点是2.73。

Pacific Biosciences of California Inc股票的52周最低点是多少?

Pacific Biosciences of California Inc股票的52周最低点是0.96。

Pacific Biosciences of California Inc的市值是多少?

Pacific Biosciences of California Inc的市值是507.29M。

现在Pacific Biosciences of California Inc(PACB)的股票是买入、持有还是卖出?

根据分析师评级,Pacific Biosciences of California Inc(PACB)的总体评级为买入,目标价格为2.46。

Pacific Biosciences of California Inc(PACB)股票的每股收益(EPS TTM)是多少

Pacific Biosciences of California Inc(PACB)股票的每股收益(EPS TTM)是-1.82。